PT Tunggal Idaman Abdi is an Indonesian pharmaceutical company that specializes in reproductive healthcare and offers affordable contraceptives at international quality standards. PT Tunggal Idaman Abdi manufactures Triclofem, a three monthly injectable contraceptive that has been awarded WHO PQ status in 2021. The company supplies quality products to both private and public sectors in domestic and overseas markets, with a network of sales representatives across Indonesia.
Headquarters
RT 012 RW 006
East Jakarta; Jakarta;
Postal Code: 13230
Contact Details: Purchase the PT Tunggal Idaman Abdi report to view the information.
Website: http://www.tunggal-pharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service